Related Experiment Video
Updated: Jul 9, 2025
09:13
Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
17.4K
Reverse Genetics System for Rift Valley Fever Virus.
Breanna Tercero1, Shinji Makino2,3,4,5,6
1Departments of Microbiology and Immunology, Galveston, TX, USA.
Methods in Molecular Biology (Clifton, N.J.)
|December 8, 2023
Summary
Rift Valley fever virus (RVFV) causes severe human and animal disease. Reverse genetics enables the creation of modified RVFV for research and vaccine development, offering new avenues for control.
Area of Science:
- Virology
- Molecular Biology
- Public Health
Background:
- Rift Valley fever virus (RVFV) is a significant mosquito-borne pathogen causing severe illness in humans and high mortality/morbidity in livestock.
- RVFV outbreaks result in substantial economic losses.
- Currently, no licensed vaccines or therapeutics exist for RVFV in humans or animals.
Purpose of the Study:
- To detail the experimental procedures for implementing Rift Valley fever virus reverse genetics.
- To highlight the utility of reverse genetics in studying RVFV molecular biology and pathogenesis.
- To explore the generation of live-attenuated vaccines using recombinant RVFV.
Main Methods:
- Description of experimental protocols for RVFV reverse genetics.
- Generation of infectious recombinant RVFV from cDNA.
- Introduction of specific genomic mutations to study virus-host interactions.
Main Results:
- Successful rescue of infectious recombinant RVFV with predetermined mutations.
- Demonstration of recombinant RVFV as a tool for pathogenesis studies.
- Potential for generating live-attenuated vaccine candidates.
Conclusions:
- RVFV reverse genetics is a powerful platform for understanding virus pathogenesis.
- This methodology facilitates the development of novel vaccine strategies against RVFV.
- Advancements in reverse genetics offer promising solutions for RVFV control.
